Physician profile
Brian A Batman
NPI 1235108952
$548.97
in general payments reported to CMS, 2019-2025
12 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $11.06 · 2023: $112 · 2024: $49.13 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $109.52 | 2025 | Stimulan |
| Merck Sharp & Dohme LLC | $99.24 | 2019-2025 | Bridion |
| Ferring Pharmaceuticals INC. | $73.14 | 2024-2025 | Euflexxa |
| Radius Health, INC. | $50.03 | 2019-2023 | Tymlos |
| Depuy Synthes Sales INC. | $46.48 | 2019-2023 | Monovisc, Orthovisc |
| Becton, Dickinson and Company | $46.17 | 2025 | Arista |
| Bioventus LLC | $35.61 | 2024-2025 | Durolane |
| Pacira Pharmaceuticals Incorporated | $29.02 | 2023 | Iovera |
| Boston Scientific Corporation | $19.07 | 2023 | |
| Chiesi USA, INC. | $18.13 | 2019 | |
| Pfizer INC. | $11.50 | 2019 | |
| Amgen INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Batman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.